These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9776840)

  • 1. In vitro activity of terbinafine against clinical isolates of dermatophytes.
    Arzeni D; Barchiesi F; Compagnucci P; Cellini A; Simonetti O; Offidani AM; Scalise G
    Med Mycol; 1998 Aug; 36(4):235-7. PubMed ID: 9776840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
    Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of aminosterols against dermatophytes.
    Coulibaly O; Alhanout K; L'Ollivier C; Brunel JM; Thera MA; Djimdé AA; Doumbo OK; Piarroux R; Ranque S
    Med Mycol; 2013 Apr; 51(3):309-12. PubMed ID: 22998181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of posaconazole against clinical isolates of dermatophytes.
    Barchiesi F; Arzeni D; Camiletti V; Simonetti O; Cellini A; Offidani AM; Scalise G
    J Clin Microbiol; 2001 Nov; 39(11):4208-9. PubMed ID: 11682563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
    Hazen KC
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S37-41. PubMed ID: 9594935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
    Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
    Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
    Simonetti O; Ganzetti G; Arzeni D; Campanati A; Marconi B; Silvestri C; Cirioni O; Gabrielli E; Lenci I; Kamysz W; Kamysz E; Giacometti A; Scalise G; Barchiesi F; Offidani A
    Peptides; 2009 Oct; 30(10):1794-7. PubMed ID: 19591887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method.
    Perea S; Fothergill AW; Sutton DA; Rinaldi MG
    J Clin Microbiol; 2001 Jan; 39(1):385-8. PubMed ID: 11136808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
    Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
    Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes.
    Ghannoum MA; Chaturvedi V; Espinel-Ingroff A; Pfaller MA; Rinaldi MG; Lee-Yang W; Warnock DW
    J Clin Microbiol; 2004 Jul; 42(7):2977-9. PubMed ID: 15243047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods.
    Karaca N; Koç AN
    Diagn Microbiol Infect Dis; 2004 Apr; 48(4):259-64. PubMed ID: 15062918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
    Simonetti O; Silvestri C; Arzeni D; Cirioni O; Kamysz W; Conte I; Staffolani S; Orsetti E; Morciano A; Castelli P; Scalise A; Kamysz E; Offidani AM; Giacometti A; Barchiesi F
    Mycoses; 2014 Apr; 57(4):233-9. PubMed ID: 26058322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
    Shehata AS; Mukherjee PK; Ghannoum MA
    J Clin Microbiol; 2008 Nov; 46(11):3668-71. PubMed ID: 18832129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
    Sarifakioglu E; Seçkin D; Demirbilek M; Can F
    Clin Exp Dermatol; 2007 Nov; 32(6):675-9. PubMed ID: 17714532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility testing of dermatophytes--comparison of the agar macrodilution and broth microdilution tests.
    Niewerth M; Splanemann V; Korting HC; Ring J; Abeck D
    Chemotherapy; 1998; 44(1):31-5. PubMed ID: 9444406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
    Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interlaboratory study of quality control isolates for a broth microdilution method (modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals.
    Ghannoum MA; Arthington-Skaggs B; Chaturvedi V; Espinel-Ingroff A; Pfaller MA; Rennie R; Rinaldi MG; Walsh TJ
    J Clin Microbiol; 2006 Dec; 44(12):4353-6. PubMed ID: 17050812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes.
    Simonetti O; Arzeni D; Ganzetti G; Silvestri C; Cirioni O; Gabrielli E; Castelletti S; Kamysz W; Kamysz E; Scalise G; Offidani A; Barchiesi F
    Br J Dermatol; 2009 Aug; 161(2):249-52. PubMed ID: 19438437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.